Clinical trials for Autoimmune thrombocytopenia
85 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07559331High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune ThrombocytopeniaShandong University
- RECRUITINGPhase 2NCT07362238Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPhase 2NCT07362199Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China
- RECRUITINGEarly Phase 1NCT07441525UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological DiseasesUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGPhase 2NCT07234019Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPhase 2NCT07297563Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPhase 2NCT07294365A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)Dizal Pharmaceuticals · PI: Hou
- RECRUITINGPhase 2NCT07104565Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell DisordersIncyte Corporation · PI: Incyte Medical Monitor
- RECRUITINGPHASE1, PHASE2NCT07175493A Study of CM336 in Patients With Relapsed or Refractory Autoimmune CytopeniaKeymed Biosciences Co.Ltd
- RECRUITINGPhase 3NCT07007962Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line TreatmentSanofi
- RECRUITINGPHASE2, PHASE3NCT07194850A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)argenx
- ACTIVE NOT RECRUITINGPhase 3NCT07216079Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in JapanSanofi
- RECRUITINGPhase 2NCT07095127Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune ThrombocytopeniaNuvig Therapeutics, Inc.
- RECRUITINGN/ANCT07206823Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune ThrombocytopeniaThe First Affiliated Hospital of Soochow University
- RECRUITINGPhase 2NCT07065968The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)Peking University People's Hospital · PI: Xiao-Hui Zhang, MD
- RECRUITINGN/ANCT06973356Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune ThrombocytopeniaAnhui Provincial Hospital · PI: bing xing wang, M.D
- RECRUITINGPhase 3NCT06948318A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaTakeda · PI: Study Director
- RECRUITINGPhase 3NCT07059000A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)Kedrion S.p.A. · PI: Mirella Calcinai, MD
- RECRUITINGPhase 2NCT07063199Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- RECRUITINGPHASE1, PHASE2NCT06721013A Study of Pirtobrutinib in Participants With Immune ThrombocytopeniaEli Lilly and Company · PI: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
- RECRUITINGPhase 3NCT06962631V-IMMUNE® for Immune ThrombocytopeniaOn Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. · PI: Sandra Regina Loggetto, PhD
- RECRUITINGN/ANCT07093606Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic PurpuraSohag University
- RECRUITINGPHASE1, PHASE2NCT07043946A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)Climb Bio, Inc. · PI: Study Director
- RECRUITINGPhase 2NCT06992128Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional TrialInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE1, PHASE2NCT06929299A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)Jiangsu BioJeTay Biotechnology Co., Ltd. · PI: Lei Zhang, M.D.
- RECRUITINGPHASE1, PHASE2NCT06853444A Phase 1/2 Study of ESG206 in Patients With Primary Immune ThrombocytopeniaShanghai Escugen Biotechnology Co., Ltd · PI: Ming Hou, PhD
- RECRUITINGPhase 3NCT06900920A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune ThrombocytopeniaChia Tai Tianqing Pharmaceutical Group Co., Ltd.
- RECRUITINGPhase 1NCT06880081Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)Chongqing Peg-Bio Biopharm Co., Ltd. · PI: Lei Zhang
- RECRUITINGPhase 2NCT06799611An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- RECRUITINGPhase 1NCT06826430Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune ThrombocytopeniaJuventas Cell Therapy Ltd. · PI: Mengtao Li, Dr.
- RECRUITINGPhase 3NCT06722235A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaTakeda · PI: Study Director
- RECRUITINGPHASE1, PHASE2NCT06531018Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.Renata PLC · PI: Md Manirul Islam, MBBS,FCPS
- RECRUITINGPHASE1, PHASE2NCT06776510A Clinical Study of NAD in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- RECRUITINGN/ANCT06813157Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune ThrombocytopeniaGuangzhou Bio-gene Technology Co., Ltd
- RECRUITINGPHASE1, PHASE2NCT07017725A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaCASI Pharmaceuticals, Inc. · PI: Junping Chen
- RECRUITINGN/ANCT07068126Management of Children With Persistent ITP, A Novel ApproachAssiut University · PI: Mervat M A Youssef, Assistant Professor
- RECRUITINGPhase 2NCT06686927Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITPUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGN/ANCT06715215Role of Acute Phase Proteins In Diagnosis of Immune ThrombocytopeniaSohag University
- ACTIVE NOT RECRUITINGPhase 2NCT06594146Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)Keymed Biosciences Co.Ltd · PI: Lei Zhang
- RECRUITINGEarly Phase 1NCT06888960Safety Study of CC312 in Autoimmune Disease PatientsCytoCares Inc
- RECRUITINGPhase 3NCT06544499A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopeniaargenx
- RECRUITINGNCT06919341RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune ThrombocytopeniaFundación Española de Hematología y Hemoterapía
- RECRUITINGNCT06817395Cognitive Dysfunction in Chronic and Persistent Immune ThrombocytopeniaMassachusetts General Hospital
- RECRUITINGPhase 1NCT06787989BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune DiseasesiCell Gene Therapeutics
- RECRUITINGEarly Phase 1NCT06337474An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune ThrombocytopeniaChangzhou No.2 People's Hospital
- RECRUITINGEarly Phase 1NCT06519565Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · PI: Heng Mei, Ph.D&M.D
- RECRUITINGPhase 2NCT06838962Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- RECRUITINGN/ANCT06479291The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITPYunfeng Cheng · PI: Yunfeng Cheng
- RECRUITINGPhase 2NCT06478537TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationPeking Union Medical College Hospital · PI: Tienan Zhu, M.D.
- RECRUITINGPhase 2NCT06658834A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITPInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGN/ANCT06479317The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITPYunfeng Cheng · PI: Yunfeng Cheng
- RECRUITINGN/ANCT06479304The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITPYunfeng Cheng · PI: Yunfeng Cheng
- RECRUITINGPHASE1, PHASE2NCT06352281Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)920th Hospital of Joint Logistics Support Force of People's Liberation Army of China · PI: Sanbin Wang, Doctor
- RECRUITINGPhase 2NCT06168851Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- RECRUITINGN/ANCT05694325Biologic Characterization of Patients With ITPGruppo Italiano Malattie EMatologiche dell'Adulto · PI: Elisa Lucchini
- RECRUITINGNCT06107582Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- RECRUITINGPhase 3NCT06004856Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune ThrombocytopeniaBeijing InnoCare Pharma Tech Co., Ltd.
- RECRUITINGPhase 2NCT06577909Prednisone Plus IVIg vs. Prednisone for ITP During PregnancyPeking University People's Hospital · PI: Xiaohui Zhang, Professor
- RECRUITINGPhase 2NCT05995054A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- ACTIVE NOT RECRUITINGPhase 2NCT05885555A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of TherapiesNovartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- RECRUITINGPhase 2NCT05599880The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune ThrombocytopeniaSeoul National University Hospital · PI: Dong-Yeop Shin, MD, PhD
- RECRUITINGNCT06757257Special Drug Use-results Survey for Long-term Use (Fostamatinib)Kissei Pharmaceutical Co., Ltd.
- ACTIVE NOT RECRUITINGPhase 3NCT06497036Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune ThrombocytopeniaGeropharm · PI: Bulat Bakirov, MD
- ACTIVE NOT RECRUITINGPhase 3NCT05653349Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)Novartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPhase 3NCT05653219A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed SteroidsNovartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPhase 2NCT05562882A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, M.D.
- ACTIVE NOT RECRUITINGPhase 3NCT05325593Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune ThrombocytopeniaFundación Pública Andaluza para la gestión de la Investigación en Sevilla · PI: Charlotte Bradbury
- RECRUITINGPhase 3NCT05338190Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune ThrombocytopeniaAssistance Publique - Hôpitaux de Paris
- RECRUITINGPhase 4NCT05520892Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in ChildrenFujian Medical University Union Hospital
- RECRUITINGPhase 3NCT04968899IgIV Plus Prednisone vs High-dose Dexamethasone for ITPAssistance Publique - Hôpitaux de Paris
- RECRUITINGPhase 2NCT05214391A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune ThrombocytopeniaInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- RECRUITINGPhase 2NCT05070845Safety and Efficacy Study of PF-06835375 in Primary Immune ThrombocytopeniaPfizer · PI: Pfizer CT.gov Call Center
- RECRUITINGNCT05152238ITP Registry and Accompanying Biospecimen CollectionJena University Hospital · PI: Thomas Stauch, Dr. med.
- ACTIVE NOT RECRUITINGPhase 3NCT04812925A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopeniaargenx
- ACTIVE NOT RECRUITINGPhase 3NCT05029635Phase III Study on HMPL-523 for Treatment of ITPHutchison Medipharma Limited · PI: Renchi Yang, professor
- RECRUITINGPhase 2NCT04993885Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With AutoantibodiesInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, M.D.
- RECRUITINGN/ANCT04890041TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 YearsInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang
- RECRUITINGPhase 1NCT04323748Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic PurpuraNew York Medical College · PI: Jordan Milner, MD
- ACTIVE NOT RECRUITINGPhase 3NCT04562766Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)Principia Biopharma, a Sanofi Company
- RECRUITINGPhase 4NCT04518475Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in AdultsInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, M.D., Ph.D
- RECRUITINGNCT06556888Observatory of Immunological Thrombopenic Purpura in the Brest RegionUniversity Hospital, Brest · PI: Brigitte Pan-Petesch, MD
- RECRUITINGNCT04005638Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune CytopeniaUniversity Hospital, Bordeaux · PI: Jean-François VIALLARD, Prof
- RECRUITINGNCT03998059Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia PatientsInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- ACTIVE NOT RECRUITINGPhase 4NCT03201848The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune ThrombocytopeniaQidong Gaitianli Medicines Co., Ltd · PI: Runming Jin, Professor
- RECRUITINGNCT05937828OBS'CEREVANCE: French Cohort of Pediatric Autoimmune CytopeniaUniversity Hospital, Bordeaux · PI: Nathalie ALADJIDI, MD